Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumour cells. Their introduction a decade ago marked a major advance in cancer therapy, but only 10 per cent to 30 per cent of treated patients experience long-term improvement.
Scientists have identified a drug that could be a game-changer for patients. Istradefylline, which is already approved for Parkinson's disease, could reduce not only the harmful effects of cisplatin but also improve its anti-tumour properties.
The amount of glucose (sugar) consumed by internal organs rises during intense aerobic exercise, according to the researchers, which decreases the amount of energy available to the tumour. The study discovered how probability of cancer metastatic spread can be reduced by aerobic exercise.
With over 2 million new cases each year, colon cancer is the third most prevalent disease in the world. The majority of patients receive their diagnosis while the tumour is still in the colon or rectum.
Cancer cells require proteins that bind copper ions in order to develop and spread throughout the human body. Recent studies on the interactions between proteins and how they bind to metals in cancer-related proteins have revealed possible new therapeutic targets.
An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to significant tumour regression in mice, report investigators.
California and Denmark researchers received Novel Prize in Chemistry for developing "click" chemistry, a method for linking molecules like LEGOs that could be a more effective manner of transferring medications to cancer tumours.
Nick Cannon's alleged girlfriend Alyssa Scott recently took to Instagram to post a bunch of photos confirming that she is pregnant with Nick Cannon's 12th child
In September, researchers from California and Denmark were awarded a Nobel Prize in Chemistry for their development of 'click' chemistry, a process in which molecules snap together like LEGO, making them a potentially more efficient transportation device in delivering pharmaceuticals to canc
A team of Canadian researchers from Universite de Montreal has designed and validated a new class of drug transporters made of DNA that are 20,000 times smaller than a human hair and that could improve how cancers and other diseases are treated